Veracyte (VCYT) Tops Q1 EPS by 4c

Veracyte (NASDAQ: VCYT) reported Q1 EPS of ($0.20), $0.04 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $67.8 million versus the consensus estimate of $62.32 million.

GUIDANCE:

Veracyte sees FY2022 revenue of $265-275 million, versus the consensus of $270 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.

You May Also Be Interested In

• Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02
• Westport Fuel Systems (WPRT) Misses Q2 EPS by 64c
• Immunome, Inc. (IMNM) Reports Q2 Loss of $0.65